National Conference of Hellenic Sepsis Study Group The pandemic caused by the new coronavirus SARS-CoV-2 (disease COVID-19) was the springboard for the emergence of the Greek Sepsis Study Group as a protagonist of international therapeutic developments in the treatment of patients with serious infections. After the authorization of the drug anakinra for the treatment of
ImmunoSep: Read more Download the Program 🡇 Abstract book 🡇 Available speakers' presentations (published with their granted permission): Jeremie Poschmann, Nantes University, France Despoina Koulenti, University of Athens, Greece Antoni Torres, University of Barcelona, Spain Antigone Kotsaki, Hellenic Institute for the Study of Sepsis, Greece Frank
Precision Management of Severe Infections and Sepsis: from Translational Research to Clinical Practice Download the Programme ⤵ PROGRAM DETAILS: Hours : 20 hours and 45 minutes REGISTRATION FEE FOR PARTICIPATION: € 140,00 + Vat 24% - Total € 173,60 Includes: Access to 2 days sessions, coffee breaks, congress material.
Download the Programme ⤵
